H19 inhibits HCC cell migration by Hnrnpu/PCAF/RNA Pol-II or activates the miR-200 family by increasing histone acetylation, thereby inhibiting HCC metastasis [73]. The gene discussed is KAT2B; the disease is hepatocellular carcinoma.